Nutrition

All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health’s Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

CV Sciences Welcomes Enactment of Federal Legislation Providing Additional Time for a Responsible, Science-Based Hemp Regulatory Framework

Legislation delays implementation of new federal hemp restrictions until December 11, 2026, preserving continued access to naturally derived hemp products...

Medical Care Technologies Inc. (OTCID:MDCE) Shows Investors a Multi-Platform Company: AI Health, Enterprise Vision, Consumer Apps, and Revenue-Generating Subsidiaries

One AI Vision Core. Multiple Commercial Tracks Across Health, Agriculture, Foodservice, Consumer Wellness, Authentication, and Auctions. MESA, AZ / ACCESS...

Medical Care Technologies Inc. (OTCID:MDCE) Activates Volunteer Intake for Melanoma Scan Beta After Launching First Human-Submitted Dataset Initiative

Follow-Up to August 31 Announcement: First Cohort Process Is Now Open for Real-World Image Testing MESA, AZ / ACCESS Newswire...

Additional Infant Patient to Receive Jaguar Health’s Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

Jaguar remains sharply focused on its ongoing global development program for oral crofelemer as adjunctive therapy to parenteral support (PS)...

Medical Cate Technologies Inc. (OTCID:MDCE) Melanoma Scan Beta Targets the Visual Race Against Time in America’s Deadliest Common Skin Cancer

Company Advances AI-Assisted Imaging Tools Designed to Help Users Track Possible Early Warning Signs and Visible Changes Over Time MESA,...

Medical Care Technologies Inc. (OTCID:MDCE) Melanoma Scan Beta Seeks First Volunteer Cohorts for Human-Submitted Image Dataset Testing

Company Advances Beyond Public Cancer Imaging Datasets With First Real-World User-Submitted Testing Phase MESA, AZ / ACCESS Newswire / August...

error: Content is protected !!